Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-04 4:06 pm | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 17,842,500 | $200 | $3,568,500,000 | 125,045,741 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-01 Exercise | 2025-04-03 5:04 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 35,444 | $174.43 | 1,488,482 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:04 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 16,477 | $119.96 | 1,488,482 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:04 pm | N/A 2029-06-04 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 674,973 | $0 | 1,488,482 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:53 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 11,689,025 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:53 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 11,689,025 (Direct) | View |
| 2025-03-11 Gift | 2025-03-13 4:43 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 158,717 | $0 | 10,060,378 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 5:02 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 497,822 | $0.5 | 50,110,738 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 5:02 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 41,210 | $6.5 | 50,110,738 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 5:02 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,033,552 | $0 | 50,110,738 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 8:17 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 708,747 | $0.5 | 51,144,290 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 8:17 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 58,590 | $6.5 | 51,144,290 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 8:17 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,470,417 | $0 | 51,144,290 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:26 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 201,084 | $0 | 52,614,707 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-07 7:26 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 486,161 | $0.5 | 52,614,707 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-07 7:26 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 40,109 | $6.5 | 52,614,707 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-07 7:26 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,007,578 | $0 | 52,614,707 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:24 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 103,883 | $0 | 230,568 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 7:24 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 7,048 | $169.65 | 230,568 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 7:24 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 44,873 | $119.96 | 230,568 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 7:24 pm | N/A 2028-04-29 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 674,973 | $0 | 230,568 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:22 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 69,251 | $0 | 1,722,136 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:20 pm | N/A N/A | BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel | 40,209 | $0 | 246,142 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 7:19 pm | N/A N/A | BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer | 48,581 | $0 | 167,128 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:59 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,220,531 | $0.5 | 53,627,732 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:59 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 101,000 | $6.5 | 53,627,732 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:59 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 2,533,531 | $0 | 53,627,732 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 6:12 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 51,921 | $169.65 | 1,547,415 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 6:12 pm | N/A 2028-04-29 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 674,973 | $0 | 1,547,415 (Direct) | View |
| 2025-02-04 Exercise | 2025-02-06 4:44 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 12,496,520 (Direct) | View |
| 2025-02-04 Exercise | 2025-02-06 4:44 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 12,496,520 (Direct) | View |
| 2025-01-07 Exercise | 2025-01-08 5:08 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 13,039,400 (Direct) | View |
| 2025-01-07 Exercise | 2025-01-08 5:08 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 13,039,400 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 5:02 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,300,000 | $0.5 | 59,140,096 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 5:02 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,300,000 | $0 | 59,140,096 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:18 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 13,582,280 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:18 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 13,582,280 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-29 4:31 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 38,461 | $6.5 | 10,325,000 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-29 4:31 pm | N/A 2025-06-29 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 499,993 | $0 | 10,325,000 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 7:21 pm | N/A 2034-09-29 | BeiGene Ltd. | BGNE | Sharp Shalini Director | 25,389 | $0 | 25,389 (Direct) | View |
| 2024-08-12 Gift | 2024-08-14 5:27 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 301,457 | $0 | 10,453,563 (Direct) | View |
| 2024-08-09 Option Award | 2024-08-13 5:17 pm | N/A 2034-08-08 | BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer | 339,534 | $0 | 339,534 (Direct) | View |